Surgery

Mapping residual esophageal tumors—a glimpse into the future?

It's one of the first questions asked by many newly-diagnosed cancer patients—"What are my chances of beating this?" Often there is no clear answer, with survival rates differing widely depending on the cancer stage and ...

Diseases, Conditions, Syndromes

Sentinel lymph node biopsy underused in high-risk SCC

(HealthDay)—Sentinel lymph node biopsy (SLNB) is underused for high-risk squamous cell carcinoma (SCC) of the skin, according to a research letter published online Nov. 15 in JAMA Dermatology.

Oncology & Cancer

Insurance plays significant role in breast cancer disparities

Differences in insurance account for a substantial proportion of the excess risk of death from breast cancer faced by black women, according to a new study. The study, appearing in Journal of Clinical Oncology, concludes ...

Oncology & Cancer

Tumor gene test results can differ in same patients

A preliminary study comparing two commercially available, next-generation genetic sequencing tests in the same cancer patients shows results can differ widely. The findings are reported Dec. 15 in JAMA Oncology.

Oncology & Cancer

Patient, tumor characteristics for high-mitotic rate melanoma

A study in Australia examined patient and tumor characteristics for melanomas with higher mitotic rates (a marker of tumor cell growth) in an effort to increase earlier detection of this aggressive cancer in patients.

page 1 from 4